Brief: India's Sun Pharma Advanced Research March-Quarter Loss Widens
May 22 (Reuters) - Sun Pharma Advanced Research Co Ltd
SPRC.NS :
* INDIA'S SUN PHARMA ADVANCED RESEARCH MARCH-QUARTER LOSS
819.9
MILLION RUPEES VERSUS LOSS 710.5 MILLION RUPEES
* SUN PHARMA ADVANCED RESEARCH MARCH-QUARTER REVENUE FROM
OPERATIONS 476.9 MILLION RUPEES VERSUS 252.4 MILLION RUPEES
* SUN PHARMA ADVANCED RESEARCH - SEEKING APPROVAL FROM
SHAREHOLDERS TO RAISE FUNDS FOR UPTO 18 BILLION RUPEES
Source text for Eikon: ID:nBSE6K50B2
Further company coverage: SPRC.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees